Add To Watchlist

LIPITOR-PATENT

The Wire

Pfizer: US ruling maintains Lipitor patent term

The U.S. Patent & Trademark Office on Tuesday issued a notice allowing drugmaker Pfizer Inc. to correct a technical defect in one of the patents involving Pfizer's cholesterol medicine Lipitor, the world's top-selling drug.

The Vine
This area needs news. Click here to seed the vine